- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
ATL announces SonoCT upgrade
ATL Ultrasound has launched the second generation of its SonoCT Real-time Compound Imaging ultrasound technology—which was the industry’s first tomographic ultrasound system. It will show the new system at this year’s RSNA
ATL Ultrasound has launched the second generation of its SonoCT Real-time Compound Imaging ultrasound technologywhich was the industrys first tomographic ultrasound system. It will show the new system at this years RSNA meeting.
Second-generation SonoCT imaging brings the technology to a broader range of scanheads and merges it with advanced signal processing technologies, such as tissue harmonic imaging, and display technologies such as 3-D and panoramic ultrasound.
SonoCT imaging processes up to nine distinct lines of sight and compounds them in real-time, resulting in images that contain diagnostic information unobtainable by conventional single-line-of-sight ultrasound. Second-generation SonoCT imaging is available on the HDI 5000 or as an upgrade option for existing HDI 5000 systems.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
